Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032 - Growing Use of Biologics and Biosimilars, Technological Advancements, and Active Product Developments

The drug delivery devices market offers opportunities in self-administration, home healthcare, and biologics due to rising chronic diseases. North America dominates this growing market with advanced infrastructure and R&D support. Key players include Pfizer, Johnson & Johnson, and AstraZeneca, driving technological developments.

Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering.

The global drug delivery devices market is projected to expand from USD 492.13 billion in 2024 to USD 760.98 billion by 2032, reflecting a substantial CAGR of 5.66% from 2025 to 2032. This growth is propelled by the increasing prevalence of chronic diseases, heightened demand for self-administration and home healthcare, the growing use of biologics and biosimilars, technological advancements, and active product development by market leaders.

Regional Insights

North America leads the market, driven by the high incidence of chronic diseases and advanced healthcare infrastructure. Significant R&D investments, favorable regulations, and a robust presence of major players bolster this dominance. The region's appetite for self-administration devices and home healthcare solutions further accelerates growth in the U.S. and Canada.

Leading Market Players

The market's competitive landscape is shaped by prominent companies such as Pfizer, Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche, Ltd., Novartis AG, 3M, Bayer AG, GlaxoSmithKline plc., and AstraZeneca PLC. These players leverage their scale, product innovation, and strategic positioning to maintain market leadership.

Technological Innovations

AI advancements are transforming drug delivery, enabling smart, precise, and adaptive systems that enhance therapeutic outcomes. AI-driven nanorobots and intelligent drug release mechanisms represent the forefront of innovation, facilitating targeted and responsive treatment regimens.

Market Drivers

• Prevalence of chronic diseases like diabetes, cancer, and respiratory conditions amplifies demand for drug delivery devices. These conditions necessitate precise medication, driving adoption of devices such as insulin pens and wearable injectors to enhance treatment efficacy and patient compliance.

• Self-administration and home healthcare trends push the demand for user-friendly devices like auto-injectors and wearable systems, catering to patient preferences for convenience and cost-efficiency, while advancements in digital health support this growth.

• Biologics and biosimilars, requiring specialized delivery methods, drive the demand for innovative devices. As their adoption rises in treating complex conditions, the need for precise delivery solutions expands.

Key Trends and Opportunities

• The shift towards biologics and self-administration is fostering device innovation, while digital technologies enhance patient engagement and adherence.

• Regulatory support and market dynamics in regions like Europe and Asia-Pacific present new opportunities for growth and innovation in drug delivery solutions.

Companies Featured

• Pfizer, Inc.

• Johnson & Johnson Services Inc.

• F. Hoffmann-La Roche

• Novartis AG

• 3M

• Bayer AG

• GlaxoSmithKline plc.

• AstraZeneca PLC

• Becton Dickinson

• Boehringer Ingelheim group

• Insulet Corporation

• Medtronic

• West Pharmaceuticals Services, Inc.

• Generex Biotechnology

• Panacea Pharmaceuticals Inc.

• Aptar Pharma

• Koninklijke Philips N.V.

• Biocorp Production.

• Terumo Corporation

• Eli Lilly and Co

For more information about this report visit https://www.researchandmarkets.com/r/1tn2v0

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900